Broker Tips
Broker tips: Victrex, Great Portland
Analysts at Berenberg lowered their target price on high performance polymers business Victrex from 1,680. 0p to 1,491. 0p on Thursday, stating the group was "not out of the woods yet".
Jefferies upgrades Great Portland Estates after rights issue
Jefferies has upgraded its rating for real estate group Great Portland from 'underperform' to 'hold' in the aftermath of the company's £350m rights issue.
Berenberg lowers target price on Victrex
Analysts at Berenberg lowered their target price on high performance polymers business Victrex from 1,680. 0p to 1,491. 0p on Thursday, stating the group was "not out of the woods yet".
Broker tips: Whitbread, GB Group, Renew Holdings, Flutter Entertainment
Jefferies reiterated its ‘buy’ rating on Whitbread but lowered its target price on the stock to 4,000. 0p from 4,200. 0p on the back of the hospitality firm’s growth plans.
Jefferies trims price target, reiterates 'buy' on Whitbread
Jefferies has reiterated its ‘buy’ rating on Whitbread, on the back of the hospitality firm’s growth plans.
Canaccord Genuity moves GB Group to 'buy'
Analysts at Canaccord Genuity raised their target price on software firm GB Group from 375. 0p to 455. 0p and moved the stock from ‘speculative buy’ to ‘buy’ on Wednesday following its full-year results a day earlier.
Berenberg nudges up target price on Renew Holdings
Analysts at Berenberg raised their target price on engineering services firm Renew Holdings from 1,250. 0p to 1,200. 0p on Wednesday following the group’s capital markets day last week.
Recent fall in Flutter's stock "excessive", says JPMorgan
JPMorgan has reiterated its 'overweight' rating on gambling group Flutter Entertainment, saying that the recent drop in the shares has been "excessive".
Broker tips: Intertek, GSK, HIkma Pharmaceuticals
Analysts at Berenberg hiked their target price on quality assurance business Intertek from 5,400. 0p to 5,500. 0p on Tuesday, citing faster-than-expected margin accretion.
Berenberg hikes target price on Intertek
Analysts at Berenberg hiked their target price on quality assurance business Intertek from 5,400. 0p to 5,500. 0p on Tuesday, citing faster-than-expected margin accretion.
Zantac litigation fears overdone at GSK, says Shore Capital
Volatile moves in GSK's share price are likely to persist in the near term as a result of ongoing Zantac-related litigation, but the long-term investment case is "still appealing", according to Shore Capital, which kept a 'buy' rating on the stock.
Citi hikes Hikma price target, cites ‘healthy trends’ for injectables and US Generics
Citi lifted its price target on Hikma Pharmaceuticals on Tuesday to 2,845p from 2,770p as it said IQVIA April data highlighted "healthy trends" for injectables and US Generics.
Broker tips: DCC, FirstGroup
JPMorgan Cazenove reinstated coverage of DCC on Thursday with an 'overweight' rating and 6,700. 0p price target, stating that it was positive on the stock for three reasons.
Citi sees near-term upside for FirstGroup despite rail renationalisation plans
Citigroup has said that the Labour Party's plans to renationalise the railways could offer some near-term upside for transport firm FirstGroup despite recent concerns.
JPMorgan reinstates ‘overweight’ rating on DCC
JPMorgan Cazenove reinstated coverage of DCC on Thursday with an ‘overweight’ rating and 6,700p price target.
Broker tips: Pearson, Future, Haleon
Citi opened a 90-day "positive catalyst watch" on Pearson shares on Wednesday as it pointed to an attractive risk/reward.
Berenberg starts coverage of Haleon at 'buy'
Berenberg initiated coverage of consumer health company Haleon on Wednesday with a ‘buy’ rating and 407p price target.
Berenberg upgrades Taylor Wimpey to 'buy'
Berenberg has upgraded Taylor Wimpey to ‘buy’ following a review of UK housebuilders ahead of next month’s general election.
Future's stock has further to run, says JPMorgan
JPMorgan has recommended keeping an 'overweight' position in shares of Future despite the huge jump in the British publisher's stock over the past year, saying the investment case is still "compelling" at these levels.
Citi opens 90-day ‘positive catalyst watch’ on Pearson shares
Citi opened a 90-day "positive catalyst watch" on Pearson shares on Wednesday as it pointed to an attractive risk/reward.